Interview with Larry Weiss, MD founder and CEO of Symbiome

In today's episode we had the opportunity to interview Larry Weiss, MD who is the founder and CEO of Symbiome and Weiss Bioscience, Inc., a San Francisco-based microbiome research and development company. Prior to this he was the Founding Chief Medical Officer at AOBiome, and before that he was the founder and CSO of CleanWell Company. Dr. Weiss has an MD from Stanford University and a BS in Biochemistry from Cornell University. He has an extensive background in natural products chemistry, microbiology, clinical medicine, biophysics, pharmaceutical, and skin care product development. Join us in today's episode as we talk about the skin microbiome, postbiotics in skincare, a unique postbiotic skincare company called Symbiome, and what the future of skincare looks like. Listen to the episode on Apple Podcasts, Spotify, Google Podcasts, Stitcher, TuneIn, or on your favorite podcast platform. Topics Covered: What is the skin microbiome How does an imbalanced skin microbiome affect our skin What are postbiotics How does Symbiome differ from other postbiotic skincare companies What the future of skincare looks like Connect With Us: Check out the Symbiome collection here (we’re loving The Renewal daily cleanser and The Answer reparative serum) Connect with Dr. Weiss on LinkedIn and Instagram Connect with Dr. Bryant Esquejo on Instagram, Youtube, and TikTok Interested in becoming a patient in Los Angeles? Schedule an appointment online here! Visit Dr. Bryant’s website: http://www.drbryantesquejo.com Connect with Dr. Marilyn Merola on Instagram and TikTok Interested in an aesthetic treatment in San Diego? Schedule a free 15-min phone consultation online here! Struggling with adult acne? Check out Dr. Merola’s holistic acne course Glow From Within here. Use code “HOLISTICBEAUTY10” for 10% off! Visit Dr. Merola’s website: https://lucerenaturalmedicine.com Follow the Holistic Beauty Podcast on Instagram. Questions or topic requests for the podcast? Send an email to [email protected].

There are no comments yet.

Please log in to write the first comment.